Global Phase1 Study to Assess the Safety and Tolerability of AZD1208 in Advanced Solid Tumors and Malignant Lymphoma
Clinical trial NCT01588548 · COMPLETED
Trial details
- NCT number
- NCT01588548
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2014-07-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.